Literature DB >> 4865980

Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States.

M W Eklund, F T Poysky, D I Wieler.   

Abstract

Some of the physiological and biochemical characteristics of a type F strain recently isolated from the United States were studied and compared with those of the prototype Langeland type F strain. The recent isolates were nonproteolytic, fermented sucrose and ribose, produced spores of low thermal resistance, produced a protoxin activated by trypsin, and grew and produced toxin at 38 F (3.3 C) from a spore inoculum. The prototype Langeland strain was proteolytic, did not ferment sucrose or ribose, and produced spores of relatively high thermal resistance, and the toxin of 3-day-old cultures was not activated by trypsin. Approximately two to three times the minimal lethal dose (MLD) of type F toxin from either Langeland or nonproteolytic strains was cross-neutralized by 1,000 anti-MLD of type E antitoxin. Antitoxin serums prepared by immunizing rabbits with the toxoid of the nonproteolytic type F isolate neutralized the toxin of the Langeland strain, but did not show cross-neutralization with the toxins of other types of Clostridium botulinum.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4865980      PMCID: PMC547191          DOI: 10.1128/am.15.6.1316-1323.1967

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  11 in total

1.  DEFORMITY OF FORELIMB IN RATS: ASSOCIATION WITH HIGH DOSES OF ACETAZOLAMIDE.

Authors:  W M LAYTON; D W HALLESY
Journal:  Science       Date:  1965-07-16       Impact factor: 47.728

2.  Some new media for the isolation and identification of Clostridia.

Authors:  A T WILLIS; G HOBBS
Journal:  J Pathol Bacteriol       Date:  1959-04

3.  Recent observations on type E botulism.

Authors:  C E DOLMAN
Journal:  Can J Public Health       Date:  1957-05

4.  A medium for the identification of clostridia producing opalescence in egg-yolk emulsions.

Authors:  A T WILLIS; G HOBBS
Journal:  J Pathol Bacteriol       Date:  1958-04

5.  Activation of Clostridium botulinum type E toxin by trypsin.

Authors:  J T DUFF; G G WRIGHT; A YARINSKY
Journal:  J Bacteriol       Date:  1956-10       Impact factor: 3.490

6.  The Egg Yolk Plate Reaction for the Presumptive Diagnosis of Clostridium sporogenes and Certain Species of the Gangrene and Botulinum Groups.

Authors:  L S McClung; R Toabe
Journal:  J Bacteriol       Date:  1947-02       Impact factor: 3.490

7.  Additional botulism episodes in Canada.

Authors:  C E DOLMAN
Journal:  Can Med Assoc J       Date:  1954-09       Impact factor: 8.262

8.  Clostridium botulinum Type F: Isolation from Salmon from the Columbia River.

Authors:  J M Craig; K S Pilcher
Journal:  Science       Date:  1966-07-15       Impact factor: 47.728

9.  Clostridium botulinum type F: seasonal inhibition by bacillus licheniformis.

Authors:  M W Wentz; R A Scott; J W Vennes
Journal:  Science       Date:  1967-01-06       Impact factor: 47.728

10.  Study of the nutritional requirements and toxin production of Clostridium botulinum type F.

Authors:  L V Holdeman; L D Smith
Journal:  Can J Microbiol       Date:  1965-12       Impact factor: 2.419

View more
  31 in total

1.  Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.

Authors:  B R Dasgupta; H Sugiyama
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

2.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

3.  Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

Authors:  Theresa J Smith; Karen K Hill; Gary Xie; Brian T Foley; Charles H D Williamson; Jeffrey T Foster; Shannon L Johnson; Olga Chertkov; Hazuki Teshima; Henry S Gibbons; Lauren A Johnsky; Mark A Karavis; Leonard A Smith
Journal:  Infect Genet Evol       Date:  2014-12-06       Impact factor: 3.342

4.  Effect of heat treatment on survival of, and growth from, spores of nonproteolytic Clostridium botulinum at refrigeration temperatures.

Authors:  M W Peck; B M Lund; D A Fairbairn; A S Kaspersson; P C Undeland
Journal:  Appl Environ Microbiol       Date:  1995-05       Impact factor: 4.792

5.  Thermal inactivation of nonproteolytic Clostridium botulinum type E spores in model fish media and in vacuum-packaged hot-smoked fish products.

Authors:  Miia Lindström; Mari Nevas; Sebastian Hielm; Liisa Lähteenmäki; Michael W Peck; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

6.  Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.

Authors:  M W Eklund; F T Poysky; M E Peterson; J A Meyers
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Enrichment, isolation, and cultural characteristics of marine strains of Clostridium botulinum type C.

Authors:  W P Segner; C F Schmidt; J K Boltz
Journal:  Appl Microbiol       Date:  1971-12

8.  Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1974-01

9.  Purification and properties of Clostridium botulinum type F toxin.

Authors:  K H Yang; H Sugiyama
Journal:  Appl Microbiol       Date:  1975-05

10.  Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.

Authors:  H M Solomon; R K Lynt; D A Kautter; T Lilly
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.